Metabolic dysfunction-associated fatty liver disease and metabolic-associated steatohepatitis: a review of pathogenesis and potential pharmacological targets
Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is one of the most common liver diseases that results from excess fat accumulation in the hepatocytes. The progression of steatosis to hepatocellular necrosis and inflammation leads to metabolic-associated steatohepatitis (MASH...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Kashan University of Medical Sciences and Health Services
2022-01-01
|
| Series: | Fiyz̤ |
| Subjects: | |
| Online Access: | http://feyz.kaums.ac.ir/article-1-4634-en.html |